E/M Coding Alert - 2020 Issue 4
Novel Coronavirus Round-Up: Feds Offer Plethora of Guidance to Combat Novel Coronavirus
Subscribe or sign in to view the full article.
Article Overview
This article summarizes early federal responses to the novel coronavirus outbreak, including CDC monitoring and symptom guidance, the HHS public health emergency declaration, CMS billing updates for laboratory testing, and federal research efforts related to vaccines and therapeutics. It is relevant to Medicare providers, laboratories, compliance staff, and others tracking public health policy and coronavirus-related administrative guidance.
Why This Topic Matters
It helps readers understand how federal agencies were responding to COVID-19 and where coding, billing, and public health guidance were changing during the early outbreak period.
Article Sections
-
Backstory
Overview of the outbreak context, CDC monitoring activity, and the general types of clinical guidance being released during the early response period.
-
Public health
Discussion of the federal public health emergency response and related announcements from HHS and international health authorities.
-
HCPCS code for lab test
Coverage of the CMS laboratory testing update and the related billing guidance for coronavirus-related testing.
-
Vaccine update
Summary of federal collaboration efforts related to coronavirus therapeutics and vaccine development.
What You Will Learn
- How federal agencies were responding to the emerging coronavirus outbreak
- What kinds of CDC and HHS updates were being issued during the early pandemic period
- How CMS addressed billing-related changes for coronavirus laboratory testing
- What federal research efforts were underway for vaccines and therapeutics
Who Should Read This
- Medicare providers
- Laboratories
- Medical coders
- Billing staff
- Compliance professionals
- Healthcare administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com